US Stock MarketDetailed Quotes
OMER Omeros
- 4.150
- +0.010+0.24%
Close Oct 18 16:00 ET
- 4.000
- -0.150-3.61%
Post 19:57 ET
240.48MMarket Cap-1765P/E (TTM)
4.210High4.060Low155.25KVolume4.150Open4.140Pre Close643.44KTurnover0.28%Turnover RatioLossP/E (Static)57.95MShares5.68052wk High-1.93P/B229.79MFloat Cap1.05052wk Low--Dividend TTM55.37MShs Float30.230Historical High--Div YieldTTM3.62%Amplitude0.920Historical Low4.144Avg Price1Lot Size
Omeros Stock Forum
Sign in to post a comment
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
16
3
$Omeros (OMER.US)$ Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
7 MINUTES AGO, 9:05 AM EDT
7 MINUTES AGO, 9:05 AM EDT
$Omeros (OMER.US)$ • The ARTEMIS-IGAN trial did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo
• Proteinuria reduction in the placebo group was substantially greater than reported in other IgA nephropathy clinical trials
• Webcast conference call planned for 8:30 a.m. ET today
• Proteinuria reduction in the placebo group was substantially greater than reported in other IgA nephropathy clinical trials
• Webcast conference call planned for 8:30 a.m. ET today
$Omeros (OMER.US)$ GOOD TO SELL OFF AND TRAVEL NOW, NHAO NHAO 🤗😋🥰👌👍
$Omeros (OMER.US)$ LAST CHANCE SELL OFF AND DELETE 👹
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Next week big pharma companies such as $Biogen (BIIB.US)$ , $Sage Therapeutics (SAGE.US)$ , and $Ironwood Pharmaceuticals (IRWD.US)$ will release their quarterly earnings report.
BIGGEST MOVERS FROM THIS WEEK
$Hillstream BioPharma (HILS.US)$ shares continued to trade up this week after it announced initial results from a study...
Next week big pharma companies such as $Biogen (BIIB.US)$ , $Sage Therapeutics (SAGE.US)$ , and $Ironwood Pharmaceuticals (IRWD.US)$ will release their quarterly earnings report.
BIGGEST MOVERS FROM THIS WEEK
$Hillstream BioPharma (HILS.US)$ shares continued to trade up this week after it announced initial results from a study...
7
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Omeros (OMER.US)$ Better Sell Off get your profit, before it will open (Lower Over -1+) then ( - 💰💰💰💰💰💰💰)
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long